Informations sur le produit
- Apd668
APD 668 is an amide-based drug that has been shown to have clinical benefits in chronic treatment of type 2 diabetes. It has been shown to activate the glucagon-like peptide-1 receptor (GLP-1R) and increase the release of insulin. APD 668 decreases hepatic steatosis, insulin resistance, and inflammatory diseases associated with diabetes. APD 668 possesses pharmacokinetic properties that make it suitable for long-term treatment of type 2 diabetes. The drug is metabolized by esterases in plasma and tissues to form a fatty acid metabolite, which can be detected in plasma and urine. The drug also contains a hydroxyl group on the amide side chain that can react with benzyl groups in vivo to form a benzyloxycarbonyl derivative. This derivative is excreted into urine as a conjugate or as free metabolites.
APD 668 increases glucose levels but does not increase blood pressure.
Propriétés chimiques
Question d’ordre technique sur : 3D-FA103601 APD 668
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
